Table 3. (a) Adverse effects associated with preoperative chemotherapy; (b) Adverse effects associated with postoperative chemotherapy.
FLO (n=22) | FLOT (n=21) | Total (n=43) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Grade 1/2 |
Grade 3/4 |
Grade 1/2 |
Grade 3/4 |
Grade 1/2 |
Grade 3/4 |
|
||||||
Adverse event | No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | P-valuea |
(a) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Haematologic | |||||||||||||
Leucopenia | 8 | 36.4 | 9 | 42.9 | 7 | 33.3 | 17 | 39.5 | 7 | 16.3 | <0.0001 | ||
Neutropenia | 7 | 31.8 | 1 | 4.5 | 5 | 23.8 | 8 | 38.1 | 12 | 27.9 | 9 | 20.9 | <0.0001 |
Thrombocytopenia | 7 | 31.8 | 8 | 38.1 | 15 | 34.9 | 0.37 | ||||||
Anaemia | 19 | 86.4 | 1 | 4.5 | 12 | 57.1 | 31 | 72.1 | 1 | 2.3 | 0.46 | ||
Infection | 4 | 18.2 | 2 | 9.5 | 6 | 28.6 | 6 | 14.0 | 6 | 14.0 | 0.05 | ||
Fever |
2 |
9.1 |
|
|
6 |
28.5 |
|
|
8 |
18.6 |
|
|
0.07 |
Non-haematologic | |||||||||||||
Nausea | 16 | 72.7 | 1 | 4.5 | 16 | 76.2 | 5 | 23.8 | 32 | 74.4 | 6 | 14.0 | 0.002 |
Vomiting | 6 | 27.3 | 1 | 4.5 | 8 | 38.1 | 2 | 9.5 | 14 | 32.6 | 3 | 7.0 | 0.48 |
Fatigue | 15 | 68.2 | 13 | 61.9 | 3 | 14.3 | 28 | 65.1 | 3 | 7.0 | 0.13 | ||
Diarrhoea | 8 | 36.4 | 1 | 4.5 | 14 | 66.7 | 1 | 4.8 | 22 | 51.2 | 2 | 4.7 | 0.15 |
Mucositis | 7 | 31.8 | 9 | 42.9 | 3 | 14.3 | 16 | 37.2 | 3 | 7.0 | 0.02 | ||
Constipation | 8 | 36.4 | 5 | 23.8 | 13 | 30.2 | 0.37 | ||||||
Sensory neuropathy | 15 | 68.2 | 3 | 13.6 | 11 | 52.4 | 4 | 19.0 | 26 | 60.5 | 7 | 16.3 | 0.60 |
Fluid retention | 3 | 13.6 | 1 | 4.8 | 4 | 9.3 | 0.95 | ||||||
(b) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Haematologic | |||||||||||||
Leucopenia | 5 | 45.5 | 4 | 44.4 | 1 | 11.1 | 9 | 45.0 | 1 | 5.0 | 0.25 | ||
Neutropenia | 4 | 36.4 | 1 | 9.1 | 2 | 22.2 | 4 | 44.4 | 6 | 30.0 | 5 | 25.0 | 0.11 |
Thrombocytopenia | 2 | 18.2 | 1 | 11.1 | 3 | 15.0 | 0.86 | ||||||
Anaemia | 11 | 100 | 9 | 100 | 20 | 100 | 0.20 | ||||||
Infection | 1 | 9.1 | 1 | 9.1 | 1 | 11.1 | 2 | 10.0 | 1 | 5.0 | 0.54 | ||
Fever |
3 |
27.3 |
|
|
1 |
11.1 |
|
|
4 |
20 |
|
|
0.29 |
Non-haematologic | |||||||||||||
Nausea | 7 | 63.6 | 4 | 44.4 | 1 | 11.1 | 11 | 55.0 | 1 | 5.0 | 0.87 | ||
Vomiting | 4 | 36.4 | 3 | 33.3 | 7 | 35.0 | 0.56 | ||||||
Fatigue | 8 | 72.8 | 1 | 9.1 | 5 | 55.6 | 1 | 11.1 | 13 | 65 | 2 | 10.0 | 0.17 |
Diarrhoea | 4 | 36.4 | 2 | 22.2 | 1 | 11.1 | 6 | 30 | 1 | 5.0 | 0.43 | ||
Mucositis | 1 | 9.1 | 1 | 11.1 | 2 | 22.2 | 2 | 10.0 | 2 | 10.0 | 0.17 | ||
Constipation | 1 | 9.1 | 1 | 9.1 | 1 | 11.1 | 2 | 10.0 | 1 | 5.0 | 0.37 | ||
Sensory neuropathy | 8 | 72.7 | 4 | 44.4 | 12 | 60.0 | 0.23 | ||||||
Fluid retention |
Abbreviation: FLO=oxaliplatin, fluorouracil; FLOT=fluorouracil, oxaliplatin, docetaxel.
Fisher's exact test was used. P-values are related to the groupings grade 0–2 vs grade 3–4 for FLO vs FLOT.